Antibiotic Use after Free Tissue Reconstruction of Head and Neck Defects: Short Course vs. Long Course

Surgical Infections

Volumn 17, Issue 1, 2016, Pages 100-105

  Khariwala, Samir S ^a   Le, Bin ^a   Pierce, Brendan H G ^a   Isaksson Vogel, Rachel ^b   Chipman, Jeffrey G ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BODY MASS; DEATH; FEMALE; FLAP DEHISCENCE; FREE TISSUE GRAFT; FREE TISSUE RECONSTRUCTION; GRAFT FAILURE; HEAD AND NECK DISEASE; HOSPITALIZATION; HUMAN; INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; OPERATING ROOM; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL FLAPS; SURGICAL INFECTION; SURGICAL TECHNIQUE; TRACHEITIS; URINARY TRACT INFECTION; ADVERSE EFFECTS; AGED; HEAD; HOSPITAL READMISSION; MIDDLE AGED; NECK; PROCEDURES; RECONSTRUCTIVE SURGERY; SURGICAL WOUND INFECTION; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; FREE TISSUE FLAPS; HEAD; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NECK; PATIENT READMISSION; RECONSTRUCTIVE SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 84955300320     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2015.131     Document Type: Article

References (34)

1. Panje WR, Bardach J, Krause CJ. Reconstruction of the oral cavity with a free flap. Plast Reconstr Surg 1976;58:415-418.
2. Rinaldo A, Shaha AR, Wei WI, et al. Microvascular free flaps: A major advance in head and neck reconstruction. Acta Oto-Laryngol 2002;122:779-784.
3. Khouri RK. Free flap surgery: The second decade. Clin Plast Surg 1992;19:757-761.
4. Disa JJ, Pusic AL, Hidalgo DH, Cordeiro PG. Simplifying microvascular head and neck reconstruction: A rational approach to donor site selection. Ann Plast Surg 2001;47: 385-389.
5. Bozec A, Poissonet G, Chamorey E, et al. Radical ablative surgery and radial forearm free flap (RFFF) reconstruction for patients with oral or oropharyngeal cancer: Postoperative outcomes and oncologic and functional results. Acta Oto-Laryngol 2009;129:681-687.
6. Genden EM, Rinaldo A, Suárez C, et al. Complications of free flap transfers for head and neck reconstruction following cancer resection. Oral Oncol 2004;40:979-984.
7. Kruse AL, Luebbers HT, Gratz KW, Obwegeser JA. Factors influencing survival of free-flap in reconstruction for cancer of the head and neck: A literature review. Microsurgery 2010;30:242-248.
8. Singh B, Cordeiro PG, Santamaria E, et al. Factors associated with complications in microvascular reconstruction of head and neck defects. Plast Reconstr Surg 1999;103: 403-411.
9. Lotfi CJ, Cavalcani Rde C, Costa e Silva AM, et al. Risk factors for surgical-site infections in head and neck cancer surgery. Otolaryngol Head Neck Surg 2008;138:74-80.
10. Liu SA, Tung KC, Shiao JY, Chiu YT. Preliminary report of associated factors in wound infection after major head and neck neoplasm operation: Does the duration of prophylactic antibiotic matter? J Laryngol Otol 2008;122:403-408.
11. Strauss M, Saccogna PW, Allphin AL. Cephazolin and metronidazole prophylaxis in head and neck surgery. J Laryngol Otol 1997;111:631-634.
12. Becker GD, Parell GJ. Cefazolin prophylaxis in head and neck cancer surgery. Ann Otol Rhinol Laryngol 1979;88: 183-186.
13. Johnson JT, Yu VL, Myers EN, et al. Efficacy of two thirdgeneration cephalosporins in prophylaxis for head and neck surgery. Arch Otolaryngol 1984;110:224-227.
14. Saginur R, Odell PF, Poliquin JF. Antibiotic prophylaxis in head and neck cancer surgery. J Otolaryngol 1988;17:78-80.
15. Johnson JT, Myers EN, Thearle PB, et al. Antimicrobial prophylaxis for contaminated head and neck surgery. Laryngoscope 1984;94:46-51.
16. Johnson JT, Wagner RL, Schuller DE, et al. Prophylactic antibiotics for head and neck surgery with flap reconstruction. Arch Otolaryngol Head Neck Surg 1992;118: 488-490.
17. Weber RS, Raad I, Frankenthaler R, et al. Ampicillin-sulbactam vs clindamycin in head and neck oncologic surgery: The need for gram-negative coverage. Arch Otolaryngol Head Neck Surg 1992;118:1159-1163.
18. Johnson JT, Kachman K, Wagner RL, Myers EN. Comparison of ampicillin/sulbactam versus clindamycin in the prevention of infection in patients undergoing head and neck surgery. Head Neck 1997;19:367-371.
19. Skitarelic N, Morovic M, Manestar D. Antibiotic prophylaxis in clean-contaminated head and neck oncological surgery. J Cranio-Maxillo-Facial Surg 2007;35:15-20.
20. Fee WE Jr, Glenn M, Handen C, Hopp ML. One day vs. Two days of prophylactic antibiotics in patients undergoing major head and neck surgery. Laryngoscope 1984;94:612-614.
21. Johnson JT, Wagner RL, Schuller DE, et al. Antibiotic prophylaxis in high-risk head and neck surgery: One-day vs. five-day therapy. Otolaryngol Head Neck Surg 1986;95: 554-557.
22. Bhathena HM, Kavarana NM. Prophylactic antibiotics administration head and neck cancer surgery with major flap reconstruction: 1-Day cefoperazone versus 5-day cefotaxime. Acta Chirurg Plast 1998;40:36-40.
23. Carroll WR, Rosenstiel D, Fix JR, et al. Three-dose vs extended-course clindamycin prophylaxis for free-flap reconstruction of the head and neck. Arch Otolaryngol Head Neck Surg 2003;129:771-774.
24. Hauck RM, Nogan S. The use of prophylactic antibiotics in plastic surgery: Update in 2010. Ann Plast Surg 2013;70: 91-97.
25. Penel N, Lefabvre D, Fourier JC, et al. Risk factors for wound infection in head and neck cancer surgery: A prospective study. Head Neck 2001;23:447-455.
26. Cloke DJ, Green JE, Khan AL, et al. Factors influencing the development of wound infection following free-flap reconstruction for intra-oral cancer. Br J Plast Surg 2004; 57:556-560.
27. Karakida K, Aoki T, Yamazaki H, et al. Analysis of risk factors for surgical-site infections in 276 oral cancer surgeries with microvascular free-flap reconstructions at a single university hospital. J Infect Chemother 2010;16:334-339.
28. Cohen LE, Finnerly BM, Golas AR, et al. Perioperative antibiotics in the setting of oropharyngeal reconstruction: Less is more. Ann Plast Surg 2014. August 20. Epub ahead of print.
29. Bratzler DW, Houck PM, Surgical Infection Prevention Guideline Writers. Antimicrobial prophylaxis for surgery: An advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005;189:395-404.
30. Hoth JJ, Franklin CA, Stassen NW, et al. Prophylactic antibiotics adversely affect nosocomial pneumonia in trauma patients. J Trauma 2003;55:249-254.
31. Rafii F, Sutherland JB, Cerniglia CE. Effects of treatment with antimicrobial agents on the human colonic microflora. Ther Clin Risk Manage 2008;4:1343-1358.
32. Carroll WR, Rosenstiel D, Fix JR, et al. Three-dose vs extended-course clindamycin prophylaxis for free-flap reconstruction of the head and neck. Arch Otolaryngol Head Neck Surg 2003;129:771-774.
33. Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013;70:195-283.
34. Marschall J, Carpenter CR, Fowler S, et al. Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: Meta-analysis. BMJ 2013;346:f3147.